Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer

키워드

참고문헌 (35)

1. Piazuelo MB, "Gastric cancer: overview", Colomb Med(Cali), 44, pp.192~201 (2013)
2. Britto AV, "Stomach cancer: risk factors", Cad Saude Publica, 13(Suppl 1), pp.7~13 (1997)
3. Brenner H, "Epidemiology of stomach cancer", Methods Mol Biol, 472, pp.467~477 (2009)
4. 최남경, "Stomach Cancer Incidence, Mortality and Survival Rate in Korean Elderly Pharmacoepidemiologic Cohort (KEPEC) in1994∼1998", Cancer Research and Treatment, 35(5), pp.383~390 (2003), 대한암학회
5. Yoshida K, "The roles of surgical oncologists in the new era : minimally invasive surgery for early gastric cancer and adjuvant surgery for metastatic gastric cancer", Pathobiology, 78, pp.343~352 (2011)
6. Layke JC, "Gastric cancer : diagnosis and treatment options", Am Fam Physician, 69, pp.1133~1140 (2004)
7. 이은영, "Socioeconomic Inequalities in Stomach Cancer Screening in Korea, 2005–2015: After the Introduction of the National Cancer Screening Program", Yonsei Medical Journal, 59(8), pp.923~929 (2018), 연세대학교의과대학[DOI]
8. McLean MH, "Genetics of gastric cancer", Nat Rev Gastroenterol Hepatol, 11, pp.664~674 (2014)
9. Zhang T, "A downmodulated microRNA profiling in patients with gastric cancer", Gastroenterol Res Pract, 2017, pp.1526981~ (2017)
10. Ishimoto T, "Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation", Int J Cancer, 138, pp.1337~1349 (2016)
11. Zhou S, "MicroRNA-381 increases radiosensitivity in esophageal squamous cell carcinoma", Am J Cancer Res, 5, pp.267~277 (2014)
12. Liang Y, "Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1", Biomed Pharmacother, 75, pp.137~141 (2015)
13. Cao Q, "MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression", J Exp Clin Cancer Res, 36, pp.29~ (2017)
14. Zhang M, "MiR-381 inhibits migration and invasion in human gastric carcinoma through downregulatedting SOX4", Oncol Lett, 14, pp.3760~3766 (2017)
15. Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))Method", Methods, 25, pp.402~408 (2001)
16. Zhou H, "Enhanced iridium complex electrochemiluminescence cytosensing and dynamic evaluation of cell-surface carbohydrate expression", Chemistry, 20, pp.14736~14743 (2014)
17. Bland JM, "Survival probabilities(the Kaplan-Meier method)", BMJ, 317, pp.1572~ (1998)
18. Alberti C, "Survival analysis - the log rank test", Rev Mal Respir, 22(5 Pt 1), pp.829~832 (2005)
19. Crichton N, "Cox proportional hazards model", J Clin Nurs, 11, pp.723~ (2002)
20. Van Cutsem E, "Gastric cancer", Lancet, 388, pp.2654~2664 (2016)
21. Wang J, "Expression and role of VEGFA and miR-381 in portal vein tumor thrombi in patients with hepatocellular carcinoma", Exp Ther Med, 15, pp.5450~5456 (2018)
22. Formosa A, "MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells", Oncogene, 33, pp.5173~5182 (2014)
23. Rothschild SI, "MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma", J Thorac Oncol, 7, pp.1069~1077 (2012)
24. Li Y, "Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma", Oncotarget, 7, pp.68585~68596 (2016)
25. Chen Y, "Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer", Oncol Rep, 30, pp.1832~1840 (2013)
26. Fujino Y, "Downregulation of microRNA-100", microRNA-125b is associated with lymph node metastasis in early colorectal cancer with submucosal invasion, 2017, pp.108, 390~397
27. Shimada H, "Clinical significance of serum tumor markers for gastric cancer : a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association", Gastric Cancer, 17, pp.26~33 (2014)
28. Ucar E, "Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer", Adv Ther, 25, pp.1075~1084 (2008)
29. Takahashi Y, "The usefulness of CEA and", or CA19-9 in monitoring for recurrence in gastric cancer patients : a prospective clinical study, 2003, pp.6, 142~145
30. Mattar R, "Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer", Rev Hosp Clin Fac Med Sao Paulo, 57, pp.89~92 (2002)
31. Henry JC, "MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas", Ann Surg Oncol, 20(Suppl 3), pp.S661~666 (2013)
32. Slattery ML, "The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer", Genes Chromosomes Cancer, 56, pp.769~787 (2017)
33. Zhao FL, "Serum microRNA-195 is down-regulated in breast cancer : a potential marker for the diagnosis of breast cancer", Mol Biol Rep, 41, pp.5913~5922 (2014)
34. Zhang X, "MicroRNA-181a functions as an oncomir in gastric cancer by targeting the tumour suppressor gene ATM", Pathol Oncol Res, 20, pp.381~389 (2014)
35. Liu H, "Genomewide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer", Cancer Lett, 316, pp.196~203 (2012)

관련 논문AI추천